Internet Explorer 8 Warnung You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="http://windows.microsoft.com/de-de/windows/end-support-help">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.
Logo HTGF

News

Focus on Start-up Pitch Day: BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 10”

28. March 2018
Strategic co-operation between medical technology firms and start-ups could foster more innovation within the industry and be a decisive factor in the success of small and medium-sized businesses (SMEs). This is particularly true in light of the increasingly complex regulatory market environment through the new EU Medical Device Regulation (MDR) which came into effect almost a year ago. Which advantages More …

Migraines & headaches app M-sense receives seven-figure sum in follow-up financing

19. January 2018
Additional financing round to help expand treatment offering and open the brand up to new markets Migraine app M-sense allows users to follow a personalised and mobile migraine treatment plan, and can also learn from user data. The certified medical product is Newsenselab GmbH’s first application and has not only racked up around 80,000 users but also a number of More …

Digital health start-up neotiv secures seed funding from High-Tech Gründerfonds

16. January 2018
From basic research straight to a digital medical product: this vision has been turned into reality by neotiv. The team headed by Chief Executive Officer Dr. Chris Rehse and dementia researcher Prof. Emrah Düzel develops user-friendly apps that are able to measure the psychological effects of Alzheimer’s disease in its early stage. The Magdeburg-based start-up is thus bringing the latest More …

MedTech Radar Live 2018 Joint start-up pitch day by BVMed, Earlybird, BARMER, High-Tech Gründerfonds and Medtech zwo

10. January 2018
The German Medical Technology Association (BVMed), venture capital firm Earlybird, BARMER, High-Tech Gründerfonds and the medtech magazine “Medtech zwo” are to hold a joint start-up day. At the “MedTech Radar Live 2018” on Mai 16th 2018 in cologne young medtech founders will have the opportunity to be introduced to established medical device companies and investors. Prof. Dr. Andreas Pinkwart, North More …

GeneQuine Biotherapeutics’ Gene Therapy Program for Treatment of Knee Osteoarthritis Acquired by Flexion Therapeutics

14. December 2017
Knee osteoarthritis program developed by Hamburg-based gene therapy specialist GeneQuine Biotherapeutics acquired by Flexion Therapeutics for up to $64 million. Program holds potential to provide long-lasting pain relief and disease modification, and pending positive pre-clinical results is anticipated to enter clinical trials in 2019. GeneQuine Biotherapeutics GmbH today announced that Flexion Therapeutics, Inc. (Nasdaq: FLXN) has acquired the global rights More …

Scipio bioscience announces its seed funding

14. November 2017
Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces today the completion of its initial fundraising. A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners’ Quadrivium I seed fund and Bonn, Germany-based High-Tech Gründerfonds. These funds will fuel More …

Focus on Medical Device Regulation: BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 9”

13. November 2017
The EU Medical Device Regulation heralds a new era for the medical technology sector: in future, any company wishing to bring medical devices to market must face the requirements of this new regulatory framework. This implies a sizeable challenge for the many small and medium-sized enterprises in Germany. The 9th edition of the joint media service “MedTech Radar”, published by More …

The game changer in surgical education – breaking bones for better patient outcomes

10. October 2017
Cologne based MedTech start-up RIMASYS received financing from investor HTGF. The investment will be utilized to expand the fracture portfolio, upgrade production technology and increase international reach. RIMASYS is the worldwide sole manufacturer of life-like fractures in human specimen with intact soft tissue mantle. Enabling medical science to enhance surgical skills and the health care industry to develop better implants More …

OMEICOS Secures Extension of Series B Financing Round to Expand its Technology into Ophthalmology

4. October 2017
OMEICOS adds REMIGES Ventures as new investor and announces the incorporation of U.S. subsidiary OMEICOS Ophthalmics, Inc. OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases, today announced that it has secured an extension of its recently closed Series B financing round. The financing by US-based REMIGES Ventures will help More …

BORN2GROW supports biotech start-up Venneos with its further growth

26. September 2017
Venture capital fund BORN2GROW has invested in Stuttgart-based Venneos GmbH in the current round of series A financing. The start-up is successfully developing and marketing the CAN-Q – a silicon chip-based imaging system for analysing biological cells. “We are thrilled to have BORN2GROW on-board as a new investor, and that we will be able to benefit from its extensive expertise More …